Parkinson Disease
Conditions
Interventions
All the individuals participating in the research should realize the three intervention modalities, as follows:
1) Neurofunctional Physiotherapy (n=40): A physiotherapy intervention program based on
• To stimulate the balance
• To stimulate functional independence and activities of daily living
• To promote the improvement of gait pattern
• To improve the patients quality of life
• To reduce fall risk indicators
• To stimulate cognitive aspects
• To improve the quality of life.
2) Augmented Reality (n=40): It will be used an own intervention protocol , consisting of two weekly interventions during 50 minutes for a period of 12 weeks, using
• To stimulating postural control and static and dynamic balance
• To promote improvement in daily life activities (DLA)
• To improve gait patterns
• To stimulating cognitive aspects
• To improve quality of life
3) Virtual Reality (n=40): Participants of the study will be submitted to an intervention protocol, based on exercises in the Wii Fit software, lasting 50 minutes for 12
• Stimulate motor coordination
• Improve the capacity of double task
• Promote improvement in daily life activities
• Reduce f
Other
E02.779
Sponsors
Universidade Estadual de Londrina
Universidade Estadual de Londrina
Eligibility
Inclusion criteria
Inclusion criteria: Medical diagnosis of Parkinson's disease according to the criteria of the London Brain Bank (Hughes et al., 1992); Individuals over 50 years of age; Non-institutionalized; Mini Mental Score that does not characterize cognitive deficit; Hohen & Yahr between 1.5 to 3.0; Patients who accept to participate in the project and sign the informed consent form according to the criteria of the Research Ethics Committee of the State University of Londrina
Exclusion criteria
Exclusion criteria: Individuals who realize other therapeutic treatment other than medication, who has a change in medication during the course of the study or who have associated diseases, such as: other neurological diseases, severe heart diseases, amputations, cognitive or comprehension deficits; Alteration in the stabilization of doses of antiparkinsonian during the course of the study or more than three faults in the therapies will be considered as loss. There will be replacement of the losses to avoid influencing the statistical power of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Improvement of postural control in individuals with PD, mensured by force platform, through observation of a variation of at least 5% in pre and post intervention measurements. Data evaluated immediately before and after the intervention.;Expected outcome 2: Improvement in executive function, mensured by Trail Making Test | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Decrease in COP amplitude, velocity and área.;Expected outcome 2: Decrease in conclusion time of "Trail Making Test" parts A and B | — |
Countries
Brazil
Contacts
Public ContactHayslenne Andressa Araújo
Universidade Estadual de Londrina
Outcome results
None listed